IL-33 directly downregulates filaggrin expression in keratinocytes and in skin tissue affecting the filaggrin mediated barrier. This effect can promote skin inflammation as IL-33 also impairs human beta defensin 2 expression and amplifies Th2 related responses.
To the editor:
IL-33 is a member of the IL-1 family of cytokines that is constitutively expressed in healthy skin and was found to be increased the skin of atopic dermatitis (AD) patients. Since it can be released after tissue damage or physical stress including scratching of the skin 1 , it has been classified as an alarmin concerned with alerting the immune system 2 Fig 1A) . Investigating an impact of IL-33 on FLG transcription, we observed a tendency towards downregulation using the same experimental setup, whereas no effect of IL-33 was on FLG expression was observable in undifferentiated keratinocytes cultured in the absence of calcium ( Fig 1B) . When we analyzed keratinocytes from patients with atopic dermatitis that were kept in cell culture in a semi-confluent manner with or without Ca2 + we observed significant decreases of FLG mRNA upon stimulation with IL-33 ( Fig 1B) . The median effect on mRNA reduction was more pronounced compared to keratinocytes from healthy donors (median .54 vs .73, respectively). Subsequently, we investigated the expression of FLG mRNA in skin biopsies after incubation for 24h with IL-33 ( Fig 1C) . Here, Histological staining of FLG expression in the skin confirmed our results on the protein level.
When compared to the non-stimulated skin, addition of IL-4 or IL-33 led to a decrease of FLG protein expression in the epidermis (Fig 2) . We analysed the staining regarding intensity and area. Since existing FLG within the stratum corneum is not expected to be affected by 24h-stimulation, evaluation was restricted to keratinocytes with detectable nuclear counterstaining. By immunohistochemical staining and software-assisted analysis we measured the stained area within the epidermis and observed a significant difference between the nonstimulated and IL-33 stimulated samples (Fig 2A) . Stimulation with IL-4 also led to FLG-loss as expected (non-stimulated: 17.72%±11.92, IL-4: 8.97%±7.06, % epidermis stained, n=6). In a next step we studied the expression of FLG with fluorescence antibodies, where the signal strength is not dependent on an enzymatic reaction. Here, the intensity of staining with anti-FLG was reduced in skin samples upon IL-33 incubation (Fig 2B) . Under these conditions IL- Based on these results we hypothesize that IL-33 contributes to eczematous inflammation not only by acting as an alarmin but also by virtue of its barrier weakening function. We here observed a direct action of IL-33 on downregulation of FLG expression independent of cytokines from mast cells or Th2 cells. The observed stronger reduction in AD derived cells compared to healthy donors fits our findings of a higher expression of ST2 on the surface of AD keratinocytes in a previous study 8 .
Filaggrin expression was shown to be controlled by the AP1 (activator protein 1) family of transcriptional regulators E11 , POU-domain transcription factors E12 , and p63 E13 . Signaling of IL-33 via ST-2 may impact these pathways, since it has been shown to result in the recruitment of MyD88, IRAK, IRAK4 and TRAF6, followed by phosphorylation of the downstream targets extracellular-signal-regulated kinase1/2, p38, IB, and JUN aminoterminal kinase, finally resulting in NFB activation E14 . While the mitogen-activated protein kinases Erk1/2, p38, and JNK stimulate AP1 activity and transcription E15 , NFB has been shown to counteract AP1 by downregulation of cFos via Elk-1 E16 .
Under most experimental conditions the effect of IL-33 on FLG reduction was weaker than observed for IL-4. We recently described another IL-4-mimetic action of IL-33 regarding the regulation of human beta defensin-2 (HBD2) 9 , supporting the idea of IL-33 being a dichotomous cytokine having IL-1 family-like and Th2-associated properties.
In conclusion, we propose that IL-33 has skin barrier modulating effects apart from its well non-stimulated. paired t-test, *p<.05, **p<.005.
